BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7554193)

  • 1. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans.
    Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA
    Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is nitric oxide involved in cutaneous vasodilation during body heating in humans?
    Dietz NM; Rivera JM; Warner DO; Joyner MJ
    J Appl Physiol (1985); 1994 May; 76(5):2047-53. PubMed ID: 7520431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NG-monomethyl-L-ARG reduces the forearm vasodilator response to acetylcholine but not to methacholine in humans.
    Rongen GA; Smits P; Thien T
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):884-8. PubMed ID: 7509909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.
    Gilligan DM; Panza JA; Kilcoyne CM; Waclawiw MA; Casino PR; Quyyumi AA
    Circulation; 1994 Dec; 90(6):2853-8. PubMed ID: 7994830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-dependent NO-mediated vasodilation in humans is attenuated by peripheral alpa1-adrenoceptor activation.
    Kamper AM; de Craen AJ; Westendorp RG; Blauw GJ
    Vasc Health Risk Manag; 2005; 1(3):251-6. PubMed ID: 17319111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nitric oxide in reactive hyperemia in human forearm vessels.
    Tagawa T; Imaizumi T; Endo T; Shiramoto M; Harasawa Y; Takeshita A
    Circulation; 1994 Nov; 90(5):2285-90. PubMed ID: 7955185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide in exercise-induced vasodilation of the forearm.
    Endo T; Imaizumi T; Tagawa T; Shiramoto M; Ando S; Takeshita A
    Circulation; 1994 Dec; 90(6):2886-90. PubMed ID: 7994834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin-induced vasodilatation in the human forearm is mediated by the "nitric oxide-pathway": no evidence for involvement of the 5-HT3-receptor.
    Bruning TA; Chang PC; Blauw GJ; Vermeij P; van Zwieten PA
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):44-51. PubMed ID: 7690095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
    Calver A; Collier J; Moncada S; Vallance P
    J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
    Taddei S; Virdis A; Mattei P; Natali A; Ferrannini E; Salvetti A
    Circulation; 1995 Nov; 92(10):2911-8. PubMed ID: 7586259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
    Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
    Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of ATP-induced vasodilation in the human forearm vascular bed.
    Rongen GA; Smits P; Thien T
    Circulation; 1994 Oct; 90(4):1891-8. PubMed ID: 7923677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm.
    Cockcroft JR; Chowienczyk PJ; Brett SE; Ritter JM
    Br J Clin Pharmacol; 1994 Oct; 38(4):307-10. PubMed ID: 7530473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired endothelium-dependent vasodilation in overweight and obese adult humans is not limited to muscarinic receptor agonists.
    Van Guilder GP; Stauffer BL; Greiner JJ; Desouza CA
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1685-92. PubMed ID: 18281379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.
    Steinberg HO; Brechtel G; Johnson A; Fineberg N; Baron AD
    J Clin Invest; 1994 Sep; 94(3):1172-9. PubMed ID: 8083357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No functional involvement of 5-hydroxytryptamine1A receptors in nitric oxide-dependent dilatation caused by serotonin in the human forearm vascular bed.
    Bruning TA; van Zwieten PA; Blauw GJ; Chang PC
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):454-61. PubMed ID: 7528302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
    Cockcroft JR; Chowienczyk PJ; Brett SE; Chen CP; Dupont AG; Van Nueten L; Wooding SJ; Ritter JM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1067-71. PubMed ID: 7562470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of endothelium-derived hyperpolarizing factor to exercise-induced vasodilation in health and hypercholesterolemia.
    Ozkor MA; Hayek SS; Rahman AM; Murrow JR; Kavtaradze N; Lin J; Manatunga A; Quyyumi AA
    Vasc Med; 2015 Feb; 20(1):14-22. PubMed ID: 25648989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local L-NG-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm.
    O'Kane KP; Webb DJ; Collier JG; Vallance PJ
    Br J Clin Pharmacol; 1994 Oct; 38(4):311-5. PubMed ID: 7833219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure.
    Nakamura M; Funakoshi T; Arakawa N; Yoshida H; Makita S; Hiramori K
    J Am Coll Cardiol; 1994 Nov; 24(5):1321-7. PubMed ID: 7930256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.